Animal models of efficacy to accelerate drug discovery in malaria

Parasitology

Volumn 141, Issue 1, 2014, Pages 93-103

  Jiménez Díaz, María Belén ^a   Viera, Sara ^a   Fernández Alvaro, Elena ^a   Angulo Barturen, Iñigo ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

animal models; critical path; Drug discovery; humanised mouse; malaria

Indexed keywords

ANTIMALARIAL AGENT;

ARTICLE; DECISION MAKING; DRUG EFFICACY; ERYTHROCYTE; INFECTION; MALARIA; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG DEVELOPMENT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HAPLORHINI; HUMAN; LIFE CYCLE STAGE; MOUSE; PARASITOLOGY; PROCEDURES; TIME; TRANSGENIC MOUSE;

ANIMALS; ANTIMALARIALS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; HAPLORHINI; HUMANS; LIFE CYCLE STAGES; MALARIA; MICE; MICE, TRANSGENIC; PLASMODIUM; TIME FACTORS;

EID: 84891871942     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013000991     Document Type: Article

References (93)

1. Andersen, S. L., Ager, A., McGreevy, P., Schuster, B. G., Wesche, D., Kuschner, R., Ohrt, C., Ellis, W., Rossan, R. and Berman, J. (1995). Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. American Journal of Tropical Medicine and Hygiene 52, 159-161
2. Anderson, J.W., Sarantakis, D., Terpinski, J., Kumar, T. R., Tsai, H. C., Kuo, M., Ager, A. L., Jacobs, W. R., Jr., Schiehser, G. A., Ekins, S., Sacchettini, J. C., Jacobus, D. P., Fidock, D. A. and Freundlich, J. S. (2013). Novel diaryl ureas with efficacy in a mouse model of malaria. Bioorganic and Medicinal Chemistry Letters 23, 1022-1025. doi:10.1016/j.bmcl.2012.12.022
3. Angulo-Barturen, I. and Ferrer, S. (2012). Humanised models of infection in the evaluation of anti-malarial drugs. Drug Discovery Today: Technologies. doi:10.1016/j.ddtec.2012.07.003
4. Angulo-Barturen, I., Jiménez-Díaz, M. B., Mulet, T., Rullas, J., Herreros, E., Ferrer, S., Jiménez, E., Mendoza, A., Regadera, J., Rosenthal, P. J., Bathurst, I., Pompliano, D. L., Gómez de las Heras, F. and Gargallo-Viola, D. (2008). A murine model of falciparum-malaria by in vivo selection of competent strains in nonmyelodepleted mice engrafted with human erythrocytes. PLoS ONE 3, e2252. doi:10.1371/journal.pone.0002252
5. Apte, S. H., Groves, P. L., Roddick, J. S., V, P. d. H. and Doolan, D. L. (2011). High-Throughput multi-parameter flow-cytometric analysis from micro-quantities of plasmodium-infected blood. International Journal for Parasitology 41, 1285-1294 doi: 10.1016/j.ijpara.2011.07.010
6. Arnold, L., Tyagi, R. K., Meija, P., Swetman, C., Gleeson, J., Perignon, J. L. and Druilhe, P. (2011). Further improvements of the P. falciparum humanized mouse model. PLoS ONE, 6. doi:10.1371/journal. pone.0018045
7. Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M. and Grompe, M. (2007). Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice. Nature Biotechnology 25, 903-910 doi: 10.1038/nbt1326
8. Baniecki, M. L., Wirth, D. F. and Clardy, J. (2007). High-Throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrobial Agents and Chemotherapy 51, 716-723 doi: 10.1128/ AAC.01144-06
9. Barker, R. H., Jr., Urgaonkar, S., Mazitschek, R., Celatka, C., Skerlj, R., Cortese, J. F., Tyndall, E., Liu, H., Cromwell, M., Sidhu, A. B., Guerrero-Bravo, J. E., Crespo-Llado, K. N., Serrano, A. E., Lin, J.W., Janse, C. J., Khan, S. M., Duraisingh, M., Coleman, B. I., Angulo-Barturen, I., Jiménez-Díaz, M. B., Magán, N., Gómez, V., Ferrer, S., Martínez, M. S., Wittlin, S., Papastogiannidis, P., O'Shea, T., Klinger, J. D., Bree, M., Lee, E., Levine, M., Wiegand, R. C., Muñoz, B., Wirth, D. F., Clardy, J., Bathurst, I. and Sybertz, E. (2011). Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 55, 2612-2622. doi:10.1128/AAC.01714-10
10. Batty, K. T., Law, A. S., Stirling, V. and Moore, B. R. (2007). Pharmacodynamics of doxycycline in a murine malaria model. Antimicrobial Agents and Chemotherapy 51, 4477-4479. doi:10.1128/ AAC.00529-07
11. Bhattacharjee, A. K., Nichols, D. A., Gerena, L., Roncal, N. and Gutteridge, C. E. (2007). An in silico 3D pharmacophore model of chalcones useful in the design of novel antimalarial agents. Medicinal Chemistry 3, 317-326
12. Biagini, G. A., Fisher, N., Shone, A. E., Mubaraki, M. A., Srivastava, A., Hill, A., Antoine, T., Warman, A. J., Davies, J., Pidathala, C., Amewu, R. K., Leung, S. C., Sharma, R., Gibbons, P., Hong, D.W., Pacorel, B., Lawrenson, A. S., Charoensutthivarakul, S., Taylor, L., Berger, O., Mbekeani, A., Stocks, P. A., Nixon, G. L., Chadwick, J., Hemingway, J., Delves, M. J., Sinden, R. E., Zeeman, A. M., Kocken, C. H., Berry, N. G., O'Neill, P. M. and Ward, S. A. (2012). Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proceedings of the National Academy of Sciences, USA 109, 8298-8303. doi:10.1073/pnas.1205651109
13. Booker, M. L., Bastos, C. M., Kramer, M. L., Barker, R. H., Jr., Skerlj, R., Sidhu, A. B., Deng, X., Celatka, C., Cortese, J. F., Guerrero Bravo, J. E., Crespo Llado, K. N., Serrano, A. E., Angulo-Barturen, I., Jiménez- Díaz, M. B., Viera, S., Garuti, H., Wittlin, S., Papastogiannidis, P., Lin, J.W., Janse, C. J., Khan, S. M., Duraisingh, M., Coleman, B., Goldsmith, E. J., Phillips, M. A., Muñoz, B., Wirth, D. F., Klinger, J. D., Wiegand, R. and Sybertza, E. (2010). Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model. Journal of Biological Chemistry 285, 33054-33064. doi:10.1074/jbc.M110.162081
14. Brunner, R., Aissaoui, H., Boss, C., Bozdech, Z., Brun, R., Corminboeuf, O., Delahaye, S., Fischli, C., Heidmann, B., Kaiser, M., Kamber, J., Meyer, S., Papastogiannidis, P., Siegrist, R., Voss, T., Welford, R., Wittlin, S. and Binkert, C. (2012). Identification of a new chemical class of antimalarials. Journal of Infectious Diseases 206, 735-743. doi:10.1093/infdis/jis418
15. Burrows, J. N., Leroy, D., Lotharius, J. and Waterson, D. (2011). Challenges in antimalarial drug discovery. Future Medicinal Chemistry 3, 1401-1412. doi:10.4155/fmc.11.91
16. Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., Crabtree, J., Angiuoli, S. V., Merino, E. F., Amedeo, P., Cheng, Q., Coulson, R. M. R., Crabb, B. S., del Portillo, H. A., Essien, K., Feldblyum, T. V., Fernandez-Becerra, C., Gilson, P. R., Gueye, A. H., Guo, X., Kang/'a, S., Kooij, T.W. A., Korsinczky, M., Meyer, E. V. S., Nene, V., Paulsen, I., White, O., Ralph, S. A., Ren, Q., Sargeant, T. J., Salzberg, S. L., Stoeckert, C. J., Sullivan, S. A., Yamamoto, M. M., Hoffman, S. L., Wortman, J. R., Gardner, M. J., Galinski, M. R., Barnwell, J.W. and Fraser-Liggett, C. M. (2008). Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455, 757-763. doi:10.1038/nature07327
17. Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brund, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., Don, Y., Matile, H., Maurer, M., Morizzi, J., Nguyen, T., Papastogiannidis, P., Scheurer, C., Shackleford, D. M., Sriraghavan, K., Stingelin, L., Tang, Y., Urwyler, H., Wang, X., White, K. L., Wittlin, S., Zhou, L. and Vennerstrom, J. L. (2011). Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proceedings of the National Academy of Sciences, USA 108, 4400-4405. doi:10.1073/ pnas.1015762108
18. Chatterjee, A. K. and Yeung, B. K. S. (2012). Back to the future: Lessons learned in modern target-based and whole-cell lead optimization of antimalarials. Current Topics in Medicinal Chemistry 12, 473-483. doi:10.2174/156802612799362977
19. Chong, C. R., Chen, X., Shi, L., Liu, J. O. and Sullivan, D. J., Jr. (2006). A clinical drug library screen identifies astemizole as an antimalarial agent. Nature Chemical Biology 2, 415-416. doi:10.1038/nchembio806
20. Coatney, G. R., Collins, W. E., McWarren, W. and Contacos, P. G. (1971). The Primate Malarias, US Government Printing Office, Washington, D.C.
21. Coatney, G. R., Elder, H. A., Contacos, P. G., Getz, M. E., Greenland, R., Rossan, R. N. and Schmidt, L. H. (1961). Transmission of the M strain of Plasmodium cynomolgi to man. American Journal of Tropical Medicine and Hygiene 10, 673-678
22. Collins,W. E. (2002a). Nonhuman primate models. I. Nonhuman primate host-parasite combinations. Methods in Molecular Medicine 72, 77-84
23. Collins,W. E. (2002b). Nonhuman primate models. II. Infection of Saimiri and Aotus monkeys with Plasmodium vivax. Methods in Molecular Medicine 72, 85-92
24. Coslédan, F., Fraisse, L., Pellet, A., Guillou, F., Mordmuller, B., Kremsner, P. G., Moreno, A., Mazier, D., Maffrand, J. P. and Meunier, B. (2008). Selection of a trioxaquine as an antimalarial drug candidate. Proceedings of the National Academy of Sciences, USA 105, 17579-17584. doi:10.1073/pnas.0804338105
25. Coteron, J. M., Marco, M., Esquivias, J., Deng, X., White, K. L., White, J., Koltun, M., El Mazouni, F., Kokkonda, S., Katneni, K., Bhamidipati, R., Shackleford, D. M., Angulo-Barturen, I., Ferrer, S. B., Jiménez- Díaz, M. B., Gamo, F. J., Goldsmith, E. J., Charman,W. N., Bathurst, I., Floyd, D., Matthews, D., Burrows, J. N., Rathod, P. K., Charman, S. A. and Phillips, M. A. (2011). Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. Journal of Medicinal Chemistry 54, 5540-5561. doi:10.1021/jm200592f.
26. DiTusa, C. A., Gettayacamin, M., Kozar, M. P., Lin, A. J., Fracisco, S. D., Ohrt, C. and Magill, A. (2010). Primaquine and tafenoquine in the Plasmodium cynomolgi causal prophylactic malaria model. American Journal of Tropical Medicine and Hygiene 83, 81 doi: 10.1016/j.pt.2009.12.005
27. Ferrer, P., Tripathi, A. K., Clark, M. A., Hand, C. C., Rienhoff, H.Y., Jr. and Sullivan, D. J., Jr. (2012). Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model. PLoS ONE 7, e37171. doi:10.1371/journal.pone.0037171
28. Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R. and Nwaka, S. (2004). Antimalarial drug discovery: Efficacy models for compound screening. Nature Reviews Drug Discovery 3, 509-520. doi:10.1038/nrd1416
29. Gabrielsson, J., Dolgos, H., Gillberg, P-G. r., Bredberg, U., Benthem, B. and Duker, G. R. (2009). Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: Strategic considerations. Drug Discovery Today 14, 358-372 doi: 10.1016/j.drudis.2008.12. 011
30. Galinski, M. and Barnwell, J. (2008). Plasmodium vivax: Who cares? Malaria Journal 7, S9. doi:10.1186/1475-2875-7-S1-S9
31. Gamo, F. J., Sanz, L. M., Vidal, J., de Cózar, C., Alvarez, E., Lavandera, J. L., Vanderwall, D. E., Green, D. V., Kumar, V., Hasan, S., Brown, J. R., Peishoff, C. E., Cardon, L. R. and García-Bustos, J. F. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305-310. doi:10.1038/ nature09107
32. Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R.W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., Paulsen, I. T., James, K., Eisen, J. A., Rutherford, K., Salzberg, S. L., Craig, A., Kyes, S., Chan, M-S., Nene, V., Shallom, S. J., Suh, B., Peterson, J., Angiuoli, S., Pertea, M., Allen, J., Selengut, J., Haft, D., Mather, M.W., Vaidya, A. B., Martin, D. M. A., Fairlamb, A. H., Fraunholz, M. J., Roos, D. S., Ralph, S. A., McFadden, G. I., Cummings, L. M., Subramanian, G. M., Mungall, C., Venter, J. C., Carucci, D. J., Hoffman, S. L., Newbold, C., Davis, R.W., Fraser, C. M. and Barrell, B. (2002). Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511. doi:10.1038/ nature01097
33. Gleeson, M. P., Hersey, A. and Hannongbua, S. (2011). In silico ADME models: A general assessment of their utility in drug discovery applications. Current Topics in Medicinal Chemistry 11, 358-381. doi:10.2174/ 156802611794480927
34. Guiguemde,W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., Jiménez-Díaz, M. B., Martínez, M. S., Wilson, E. B., Tripathi, A. K., Gut, J., Sharlow, E. R., Bathurst, I., El Mazouni, F., Fowble, J.W., Forquer, I., McGinley, P. L., Castro, S., Angulo-Barturen, I., Ferrer, S., Rosenthal, P. J., Derisi, J. L., Sullivan, D. J., Lazo, J. S., Roos, D. S., Riscoe, M. K., Phillips, M. A., Rathod, P. K., Van Voorhis, W. C., Avery, V. M. and Guy, R. K. (2010). Chemical genetics of Plasmodium falciparum. Nature 465, 311-315. doi:10.1038/ nature09099
35. Guiguemde, W. A., Shelat, A. A., García-Bustos, J. F., Diagana, T. T., Gamo, F. J. and Guy, R. K. (2012). Global phenotypic screening for antimalarials. Chemistry and Biology 19, 116-129. doi:10.1016/j. chembiol.2012.01.004
36. Guo, J., Guiguemde, A.W., Bentura-Marciano, A., Clark, J., Haynes, R. K., Chan, W. C., Wong, H. N., Hunt, N. H., Guy, R. K. and Golenser, J. (2012). Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria. Antimicrobial Agents and Chemotherapy 56, 163-173. doi:10.1128/ AAC.05006-11
37. Jain, M., Vangapandu, S., Sachdeva, S., Singh, S., Singh, P. P., Jena, G. B., Tikoo, K., Ramarao, P., Kaul, C. L. and Jain, R. (2004). Discovery of a bulky 2-Tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity. Journal of Medicinal Chemistry 47, 285-287. doi:10.1021/jm0304562
38. Jiménez-Díaz, M. B., Mulet, T., Gómez, V., Viera, S., Alvarez, A., Garuti, H., Vázquez, Y., Fernández, A., Ibañez, J., Jiménez, M., Gargallo-Viola, D. and Angulo-Barturen, I. (2009a). Quantitative measurement of plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Cytometry Part A 75, 225-235. doi:10.1002/cyto. a.20647
39. Jiménez-Díaz, M. B., Mulet, T., Viera, S., Gómez, V., Garuti, H., Ibañez, J., Alvarez-Doval, A., Shultz, L. D., Martínez, A., Gargallo-Viola, D. and Angulo-Barturen, I. (2009b). Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL-2Rgnull mice engrafted with human erythrocytes. Antimicrobial Agents and Chemotherapy 53, 4533-4536 doi: 10.1128/AAC.00519-09
40. Jiménez-Díaz, M. B., Viera, S., Ibáñez, J., Mulet, T., Magán-Marchal, N., Garuti, H., Gómez, V., Cortés-Gil, L., Martínez, A., Ferrer, S., Fraile, M. T., Calderón, F., Fernández, E., Shultz, L. D., Leroy, D., Wilson, D. M., García-Bustos, J. F., Gamo, F. J. and Angulo-Barturen, I. (2013). A new paradigm to accelerate drug discovery of new antimalarials using in vivo screening. PLoS ONE. In press
41. Keldenich, J. (2009). Measurement and prediction of oral absorption. Chemistry and Biodiversity 6, 2000-2013. doi:10.1002/cbdv.200900054
42. Kelly, J. X., Smilkstein, M. J., Brun, R., Wittlin, S., Cooper, R. A., Lane, K. D., Janowsky, A., Johnson, R. A., Dodean, R. A., Winter, R., Hinrichs, D. J. and Riscoe, M. K. (2009). Discovery of dual function acridones as a new antimalarial chemotype. Nature 459, 270-273. doi:10.1038/nature07937
43. Khan, M. O. F., Levi, M. S., Tekwani, B. L., Khan, S. I., Kimura, E. and Borne, R. F. (2009). Synthesis and antimalarial activities of cyclen 4-Aminoquinoline analogs. Antimicrobial Agents and Chemotherapy 53, 1320-1324 doi: 10.1128/AAC.01304-08
44. Kinnamon, K. E. and Rothe, W. E. (1975). Biological screening in the U.S. Army antimalarial drug development program. American Journal of Tropical Medicine and Hygiene 24, 174-178
45. Kocken, C. H. M., Remarque, E. J., Dubbeld, M. A., Wein, S., Van Der Wel, A., Verburgh, R. J., Vial, H. J. and Thomas, A.W. (2009). Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria. Antimicrobial Agents and Chemotherapy 53, 421-427 doi: 10.1128/ AAC.00576-08
46. Landau, I. and Gautret, P. (1998). Animal models: Rodents. In Malaria: Parasite b, Pathogenesis and Protection (ed. Sherman, I.W.), pp. 401-417. ASM Press, Washington, D.C.
47. Lin, A., Kozar, M. P., O'Neil, M. T., Melendez, V., Saunders, D. and Magill, A. J. (2009). Lead optimization and pre-clinical studies of imidazolidinedione derivatives as malaria prophylactic agents. Tropical Medicine and International Health 14, 120
48. Lowes, D., Pradhan, A., Iyer, L. V., Parman, T., Gow, J., Zhu, F., Furimsky, A., Lemoff, A., Guiguemde, W. A., Sigal, M., Clark, J. A., Wilson, E., Tang, L., Connelly, M. C., DeRisi, J. L., Kyle, D. E., Mirsalis, J. and Guy, R. K. (2012). Lead optimization of antimalarial propafenone analogues. Journal of Medicinal Chemistry 55, 6087-6093. doi:10.1021/jm300286a.
49. Malleret, B., Claser, C., Ong, A. S., Suwanarusk, R., Sriprawat, K., Howland, S.W., Russell, B., Nosten, F. and Renia, L. (2011). A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Scientific Reports 1, 118. doi:10.1038/srep00118
50. Moore, B. R., Batty, K. T., Andrzejewski, C., Jago, J. D., Page-Sharp, M. and Ilett, K. F. (2008). Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model. Antimicrobial Agents and Chemotherapy 52, 306-311. doi:10.1128/AAC.00878-07
51. Moore, B. R., Ilett, K. F., Page-Sharp, M., Jago, J. D. and Batty, K. T. (2009). Piperaquine pharmacodynamics and parasite viability in a murine malaria model. Antimicrobial Agents and Chemotherapy 53, 2707-2713 doi: 10.1128/AAC.00056-09
52. Moore, B. R., Page-Sharp, M., Stoney, J. R., Ilett, K. F., Jago, J. D. and Batty, K. T. (2011). Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrobial Agents and Chemotherapy 55, 3899-3907 doi: 10.1128/AAC.00067-11
53. Moore, J. M., Kumar, N., Shultz, L. D. and Rajan, T. V. (1995). Maintenance of the human malarial parasite Plasmodium falciparum in scid mice and transmission of gametocytes to mosquitoes. Journal of Experimental Medicine 181, 2265-2270 doi: 10.1084/ jem.181.6.2265
54. Moreno, A., Badell, E., Van Rooijen, N. and Druilhe, P. (2001). Human malaria in immunocompromised mice: New in vivo model for chemotherapy studies. Antimicrobial Agents and Chemotherapy 45, 1847-1853. doi:10.1128/AAC.45.6.1847- 1853.2001
55. Morosan, S., Hez-Deroubaix, S., Lunel, F., Renia, L., Giannini, C., Van Rooijen, N., Battaglia, S., Blanc, C., Eling, W., Sauerwein, R., Hannoun, L., Belghiti, J., Brechot, C., Kremsdorf, D. and Druilhe, P. (2006). Liver-stage development of Plasmodium falciparum, in a humanized mouse model. Journal of Infectious Diseases 193, 996-1004. doi:10.1086/ 500840
56. Nagle, A., Wu, T., Kuhen, K., Gagaring, K., Borboa, R., Francek, C., Chen, Z., Plouffe, D., Lin, X., Caldwell, C., Ek, J., Skolnik, S., Liu, F., Wang, J., Chang, J., Li, C., Liu, B., Hollenbeck, T., Tuntland, T., Isbell, J., Chuan, T., Alper, P. B., Fischli, C., Brun, R., Lakshminarayana, S. B., Rottmann, M., Diagana, T. T., Winzeler, E. A., Glynne, R., Tully, D. C. and Chatterjee, A. K. (2012). Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents. Journal of Medicinal Chemistry 55, 4244-4273. doi:10.1021/jm300041e.
57. Nájera, J. A., González-Silva, M. and Alonso, P. L. (2011). Some lessons for the future from the Global Malaria Eradication Programme (1955-1969). PLoS Medicine 8, e1000412. doi:10.1371/ journal.pmed.1000412
58. Nilsen, A., LaCrue, A. N., White, K. L., Forquer, I. P., Cross, R. M., Marfurt, J., Mather, M.W., Delves, M. J., Shackleford, D. M., Saenz, F. E., Morrisey, J. M., Steuten, J., Mutka, T., Li, Y., Wirjanata, G., Ryan, E., Duffy, S., Kelly, J. X., Sebayang, B. F., Zeeman, A-M., Noviyanti, R., Sinden, R. E., Kocken, C. H. M., Price, R. N., Avery, V. M., Angulo-Barturen, I., Jiménez-Díaz, M. B., Ferrer, S., Herreros, E., Sanz, L. M., Gamo, F-J., Bathurst, I., Burrows, J. N., Siegl, P., Guy, R. K., Winter, R.W., Vaidya, A. B., Charman, S. A., Kyle, D. E., Manetsch, R. and Riscoe, M. K. (2013). Quinolone-3-Diarylethers: A new class of antimalarial drug. Science Translational Medicine 5, 177ra137. doi:10.1126/ scitranslmed.3005029
59. Obaldia, N., Kotecka, B. M., Edstein, M. D., Haynes, R. K., Fugmann, B., Kyle, D. E. and Rieckmann, K.H. (2009). Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 53, 3592-3594. doi:10.1128/AAC.00471-09
60. O'Brien, C., Henrich, P. P., Passi, N. and Fidock, D. A. (2011). Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Current Opinion in Infectious Diseases 24, 570-577. doi:10.1097/QCO.0b013e32834cd3ed.
61. Ockenhouse, C. F., Magill, A., Smith, D. and Milhous, W. (2005). History of U.S. military contributions to the study of malaria. Military Medicine 170, 12-16
62. Paterson, S. and Lello, J. (2003). Mixed models: Getting the best use of parasitological data. Trends in Parasitology 19, 370-375. doi:10.1016/S1471- 4922(03)00149-1
63. Payne, D. J., Gwynn, M. N., Holmes, D. J. and Pompliano, D. L. (2007). Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery 6, 29-40 doi: 10.1038/nrd2201
64. Pereira, M. R., Henrich, P. P., Sidhu, A. B., Johnson, D., Hardink, J., Van Deusen, J., Lin, J., Gore, K., O'Brien, C., Wele, M., Djimde, A., Chandra, R. and Fidock, D. A. (2011). In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrobial Agents and Chemotherapy 55, 3115-3124 doi: 10.1128/AAC.01566-10
65. Peters, W. and Robinson, B. L. (1999). Malaria. In Handbook of Animal Models of Infection (ed. Zak, O. and Sande, M. A.), pp. 757-773. Academic Press, London
66. Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrian, F., Matzen, J. T., Anderson, P., Nam, T. G., Gray, N. S., Chatterjee, A., Janes, J., Yan, S. F., Trager, R., Caldwell, J. S., Schultz, P. G., Zhou, Y. and Winzeler, E. A. (2008). In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-Throughput screen. Proceedings of the National Academy of Sciences, USA 105, 9059-9064. doi:10.1073/pnas.0802982105
67. Powles, M. A., Allocco, J., Yeung, L., Nare, B., Liberator, P. and Schmatz, D. (2012). MK-4815, a potential new oral agent for treatment of malaria. Antimicrobial Agents and Chemotherapy 56, 2414-2419. doi:10.1128/ AAC.05326-11
68. Prugnolle, F., McGee, K., Keebler, J. and Awadalla, P. (2008). Selection shapes malaria genomes and drives divergence between pathogens infecting hominids versus rodents. BMC Evolutionary Biology 8, 223. doi:10.1186/1471-2148- 8-223
69. Prugnolle, F., Ollomo, B., Durand, P., Yalcindag, E., Arnathau, C. l., Elguero, E., Berry, A., Pourrut, X., Gonzalez, J-P., Nkoghe, D., Akiana, J., Verrier, D., Leroy, E., Ayala, F. J. and Renaud, F. (2011). African monkeys are infected by Plasmodium falciparum nonhuman primate-specific strains. Proceedings of the National Academy of Sciences, USA 108, 11948-11953. doi:10.1073/pnas. 1109368108
70. Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., Cohen, S. B., Spencer, K. R., González-Páez, G. E., Lakshminarayana, S. B., Goh, A., Suwanarusk, R., Jegla, T., Schmitt, E. K., Beck, H. P., Brun, R., Nosten, F., Renia, L., Dartois, V., Keller, T. H., Fidock, D. A., Winzeler, E. A. and Diagana, T. T. (2010). Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175-1180. doi:10.1126/science.1193225
71. Sacci, J. B., Jr., Alam, U., Douglas, D., Lewis, J., Tyrrell, D. L., Azad, A. F. and Kneteman, N. M. (2006). Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. International Journal for Parasitology 36, 353-360 doi: 10.1016/j. ijpara.2005.10.014
72. Saenz, F. E., Mutka, T., Udenze, K., Oduola, A. M. J. and Kyle, D. E. (2012). Novel 4-Aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Antimicrobial Agents and Chemotherapy 56, 4685-4692. doi:10.1128/AAC.01061-12
73. Salom-Roig, X. J., Hamze, A., Calas, M. and Vial, H. J. (2005). Dual molecules as new antimalarials. Combinatorial Chemistry and High Throughput Screen 8, 49-62 doi: 10.2174/1386207053328219
74. Sanni, L. A., Fonseca, L. F. and Langhorne, J. (2002). Mouse models for eryhtrocytic-stage malaria. In Malaria Methods and Protocols (ed. Doolan, D. L.), pp. 57-76. Humana. Press, Inc., Totowa
75. Sanz, L. M., Jiménez-Díaz, M. B., Crespo, B., De Cózar, C., Almela, M. J., Angulo-Barturen, I., Castañeda, P., Ibañez, J., Fernandez, E. P., Ferrer, S., Herreros, E., Lozano, S., Martínez, M. S., Rueda, L., Burrows, J. N., García-Bustos, J. F. and Gamo, F. J. (2011). Cyclopropyl carboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screen. Antimicrobial Agents and Chemotherapy 55, 5740-5745. doi:10.1128/AAC.05188-11
76. Scheller, L. F., Wirtz, R. A. and Azad, A. F. (1994). Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei. Infection and Immunity 62, 4844-4847
77. Shultz, L. D., Brehm, M. A., García-Martínez, J. V. and Greiner, D. L. (2012). Humanized mice for immune system investigation: Progress, promise and challenges. Nature Reviews Immunology 12, 786-798. doi:10.1038/nri3311
78. Skerlj, R. T., Bastos, C. M., Booker, M. L., Kramer, M. L., Barker, R. H., Celatka, C. A., O'Shea, T. J., Munoz, B., Sidhu, A. B., Cortese, J. F., Wittlin, S., Papastogiannidis, P., Angulo-Barturen, I., Jiménez- Díaz, M. B. and Sybertz, E. (2011). Optimization of potent inhibitors of P. falciparum dihydroorotate dehydrogenase for the treatment of malaria. ACS Medicinal Chemistry Letters 2, 708-713 doi: 10.1021/ ml200143c.
79. Slater, L. B. (2005). Malarial birds: Modeling infectious human disease in animals. Bulletin of the History of Medicine 79, 261-294 doi: 10.1353/ bhm.2005.0092
80. Stewart, V. A. (2003). Plasmodium vivax under the microscope: The Aotus model. Trends in Parasitology 19, 589-594 doi: S1471492203002812
81. The malERA Consultative Group on Drugs (2011). A research agenda for malaria eradication: Drugs. PLoS Medicine 8, e1000402. doi:10.1371/ journal.pmed.1000402
82. Thompson, P. E. and Werbel, L. M. (1972). Antimalarial Agents. Chemistry and Pharmacology, Academic Press, New York
83. van der Worp, H B., Howells, D.W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V. and Macleod, M. R. (2010). Can animal models of disease reliably inform human studies? PLoS Medicine 7, e1000245. doi:10.1371/journal. pmed.1000245
84. Vaughan, A. M., Mikolajczak, S. A., Wilson, E. M., Grompe, M., Kaushansky, A., Camargo, N., Bial, J., Ploss, A. and Kappe, S. H. (2012). Complete Plasmodium falciparum liver-stage development in liverchimeric mice. Journal of Clinical Investigation 122, 3618-3628. doi:62684 doi: 10.1172/JCI62684
85. Weisman, J. L., Liou, A. P., Shelat, A. A., Cohen, F. E., Guy, R. K. and DeRisi, J. L. (2006). Searching for new antimalarial therapeutics amongst known drugs. Chemical Biology and Drug Design 67, 409-416. doi:JPP391 doi:10.1111/j.1747-0285.2006.00391.x.
86. Wengelnik, K., Vidal, V., Ancelin, M. L., Cathiard, A. M., Morgat, J. L., Kocken, C. H., Calas, M., Herrera, S., Thomas, A.W. and Vial, H. J. (2002). A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 295, 1311-1314. doi:10.1126/ science.1067236
87. White, N. J. (2008). Plasmodium knowlesi: The fifth human malaria parasite. Clinical Infectious Diseases 46, 172-173. doi:10.1086/524889
88. White, N. J. (2011). The parasite clearance curve. Malaria Journal 10, 278 doi: 1475-2875-10-278 doi:10.1186/1475-2875-10-278
89. WHO (2010a). Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010. World Health Organization, Geneva, Switzerland
90. WHO(2010b).World Malaria Report. World Health Organization, Geneva, Switzerland
91. Yeates, C. L., Batchelor, J. F., Capon, E. C., Cheesman, N. J., Fry, M., Hudson, A. T., Pudney, M., Trimming, H., Woolven, J., Bueno, J. M., Chicharro, J., Fernandez, E., Fiandor, J. M., Gargallo-Viola, D., Gomez de las Heras, F., Herreros, E. and Leon, M. L. (2008). Synthesis and structure-Activity relationships of 4-pyridones as potential antimalarials. Journal of Medicinal Chemistry 51, 2845-2852 doi: 10.1021/ jm0705760
92. Younis, Y., Douelle, F., Feng, T. S., Gonzalez Cabrera, D., Le Manach, C., Nchinda, A. T., Duffy, S., White, K. L., Shackleford, D. M., Morizzi, J., Mannila, J., Katneni, K., Bhamidipati, R., Zabiulla, K. M., Joseph, J. T., Bashyam, S., Waterson, D., Witty, M. J., Hardick, D., Wittlin, S., Avery, V., Charman, S. A. and Chibale, K. (2012). 3,5-Diaryl-2-Aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. Journal of Medicinal Chemistry 55, 3479-3487. doi:10.1021/jm3001373
93. Zhang, Y., Clark, J. A., Connelly, M. C., Zhu, F., Min, J., Guiguemde, W. A., Pradhan, A., Iyer, L., Furimsky, A., Gow, J., Parman, T., El Mazouni, F., Phillips, M. A., Kyle, D. E., Mirsalis, J. and Guy, R. K. (2012). Lead optimization of 3-carboxyl-4(1 H)-quinolones to deliver orally bioavailable antimalarials. Journal of Medicinal Chemistry 55, 4205-4219. doi:10.1021/jm201642z.